Literature DB >> 8895128

Management and treatment of central steep islands after excimer laser photorefractive keratectomy.

A Castillo1, F Romero, J A Martin-Valverde, D Diaz-Valle, N Toledano, O Sayagues.   

Abstract

BACKGROUND: Permanent central steep islands are an undesirable phenomenon that cause distorted images and a significant reduction in visual acuity. We describe treatment of central steep islands with repeat excimer laser photoablation in the central cornea.
METHODS: Three patients with preoperative refractions of -7.50 -2.50 x 170 degrees D (right eye), -8.00 -2.25 x 10 degrees D (right eye) and -6.00 -1.50 x 90 degrees (right eye) developed central steep islands which persisted more than 12 months. All patients lost more than two lines of spectacle-corrected visual acuity and complained of visual disturbances. We retreated the central steep islands with a VISX 20/20 excimer laser PRK ablation that matched the size of the central island measured on videokeratography.
RESULTS: Symptomatic glare and distortion were significantly reduced and the central steep islands were resolved. Several weeks after reablation, spectacle-corrected visual acuity improved to the preoperative level.
CONCLUSION: Central steep island, an infrequent complication of excimer laser photorefractive keratectomy, can be safely removed with a repeat laser ablation that matches the central circular steep area.

Entities:  

Mesh:

Year:  1996        PMID: 8895128     DOI: 10.3928/1081-597X-19960901-15

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  2 in total

1.  Predicting transepithelial phototherapeutic keratectomy outcomes using Fourier domain optical coherence tomography.

Authors:  Catherine Cleary; Yan Li; Maolong Tang; Nehal M Samy El Gendy; David Huang
Journal:  Cornea       Date:  2014-03       Impact factor: 2.651

Review 2.  Errors in Treatment of Lower-order Aberrations and Induction of Higher-order Aberrations in Laser Refractive Surgery.

Authors:  Brad E Kligman; Brandon J Baartman; William J Dupps
Journal:  Int Ophthalmol Clin       Date:  2016
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.